Trivector sells majority stake to Origio

AHMEDABAD: Trivector Scientific Private Ltd, an infertility treatment company, has announced its joint venture with Denmark-based ORIGIO an assisted reproductive technology (ART) solutions provider.

Origio a/s, a listed medtech company on the Oslo Stock Exchange, will acquire 51% in Trivector Scientific set up in 1993.

Consultants BDO India advised Trivector in cross-border M&A sale of majority stake. The joint venture will focus on introducing and selling more equipment, consumables, disposables, culture media, providing other maintenance services and to increase awareness about the issue in the society.

The infertility sector has been doubling every year in India and is expected to witness similar growth in the years ahead.